For researchers already on tirzepatide who want to understand how it compares to the broader landscape, the phentermine versus GLP-1 comparison provides useful context, as does the Ozempic versus retatrutide analysis
compounded), dose, and pharmacy availability
So when someone says "I'm on semaglutide," they might mean Ozempic, Wegovy, or a compounded product
Metformin reduces hepatic glucose production, improves insulin sensitivity, and may have modest effects on appetite and weight
Humana explicitly excludes weight loss as a covered indication for GLP-1 medications (a class of injectable weight loss drugs)this isn't a prior authorization denial, it's a plan exclusion that blocks claims at the pharmacy level
A new study conducted by Galdermaand one of the first aesthetics companies to examine how GLP-1 agonists specifically affect the skinfound that GLP-1s do indeed cause a different type of fat loss than traditional weight loss